Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to -$812541.0.

  • Stemtech's Net Income towards Common Stockholders fell 16941.95% to -$812541.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 227.36%. This contributed to the annual value of -$3.8 million for FY2024, which is 3054.65% up from last year.
  • As of Q3 2025, Stemtech's Net Income towards Common Stockholders stood at -$812541.0, which was down 16941.95% from -$296280.0 recorded in Q2 2025.
  • Over the past 5 years, Stemtech's Net Income towards Common Stockholders peaked at $17.4 million during Q3 2022, and registered a low of -$25.0 million during Q2 2022.
  • For the 5-year period, Stemtech's Net Income towards Common Stockholders averaged around -$1.2 million, with its median value being -$773223.0 (2021).
  • Within the past 5 years, the most significant YoY rise in Stemtech's Net Income towards Common Stockholders was 42682.98% (2022), while the steepest drop was 312906.9% (2022).
  • Stemtech's Net Income towards Common Stockholders (Quarter) stood at -$848155.0 in 2021, then surged by 36.13% to -$541732.0 in 2022, then crashed by 244.08% to -$1.9 million in 2023, then surged by 78.72% to -$396580.0 in 2024, then crashed by 104.89% to -$812541.0 in 2025.
  • Its Net Income towards Common Stockholders stands at -$812541.0 for Q3 2025, versus -$296280.0 for Q2 2025 and -$1.5 million for Q1 2025.